Cargando…

Comparative Cost-Effectiveness Analysis of Respiratory Syncytial Virus Vaccines for Older Adults in Hong Kong

Two respiratory syncytial virus (RSV) vaccines (AREXVY(®) and ABRYSVO(®)) were recently approved for older adults in the US. This study aimed to evaluate the cost-effectiveness of AREXVY(®) and ABRYSVO(®) from the Hong Kong public healthcare provider’s perspective. A two-year decision-analytical mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yingcheng, Fekadu, Ginenus, You, Joyce H. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610694/ https://www.ncbi.nlm.nih.gov/pubmed/37897008 http://dx.doi.org/10.3390/vaccines11101605

Ejemplares similares

Cost-Effectiveness Analyses of Digital Health Technology for Improving the Uptake of Vaccination Programs: Systematic Review
por: Wang, Yingcheng, et al.
Publicado: (2023)

Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting–A cost-effectiveness analysis
por: Fekadu, Ginenus, et al.
Publicado: (2023)

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
por: You, Joyce HS, et al.
Publicado: (2014)

Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States
por: Fekadu, Ginenus, et al.
Publicado: (2022)

Public health impact of herpes zoster vaccination on older adults in Hong Kong
por: Chan, Paul K. S., et al.
Publicado: (2023)

Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children
por: Leung, T. F., et al.
Publicado: (2013)

Oral Health Care of Older Adults in Hong Kong
por: Chan, Alice Kit Ying, et al.
Publicado: (2021)

Respiratory Syncytial Virus and Other Noninfluenza Respiratory Viruses in Older Adults
por: Kodama, Fumihiro, et al.
Publicado: (2017)

Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle
por: Atkins, Katherine E, et al.
Publicado: (2023)

Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis
por: Fekadu, Ginenus, et al.
Publicado: (2022)

The Seasonality of Respiratory Viruses in a Hong Kong Hospital, 2014–2023
por: Chan, Wai-Sing, et al.
Publicado: (2023)

Thoracic surgery in Hong Kong
por: Chang, Aliss T. C., et al.
Publicado: (2022)

Understanding of Resilience of Older Adults in Hong Kong: A Qualitative Investigation
por: Hu, Chun, et al.
Publicado: (2020)

The use of technology for online learning among older adults in Hong Kong
por: Fong, Ben Y. F., et al.
Publicado: (2022)

Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic—A cost-effectiveness analysis
por: Yao, Jiaqi, et al.
Publicado: (2022)

The effects of health literacy in influenza vaccination competencies among community-dwelling older adults in Hong Kong
por: Zhang, Fan, et al.
Publicado: (2020)

1941. Coadministration of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine With Influenza Vaccine in Older Adults
por: Baber, James A, et al.
Publicado: (2023)

Children with Respiratory Disease Associated with Metapneumovirus in Hong Kong
por: Peiris, J.S. Malik, et al.
Publicado: (2003)

A Cost-Effectiveness Analysis of “Test” versus “Treat” Patients Hospitalized with Suspected Influenza in Hong Kong
por: You, Joyce H. S., et al.
Publicado: (2012)

Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020)

The Quest for a Respiratory Syncytial Virus Vaccine for Older Adults: Thinking beyond the F Protein
por: Jenkins, Victoria A., et al.
Publicado: (2023)

Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during the COVID-19 pandemic in a high-income country
por: Fekadu, Ginenus, et al.
Publicado: (2021)

Plants of Hong Kong /
por: Thrower, S. L.
Publicado: (1971)

Hospital in Hong Kong
Publicado: (1892)

Melioidosis in Hong Kong
por: Lui, Grace, et al.
Publicado: (2018)

Perceptions of and hesitancy toward COVID-19 vaccination in older Chinese adults in Hong Kong: a qualitative study
por: Siu, Judy Yuen-man, et al.
Publicado: (2022)

Hong Kong Medical Journal – the Premier General Medical Journal in Hong Kong
por: Li, Kenneth KW, et al.
Publicado: (2021)

Respiratory Infections during SARS Outbreak, Hong Kong, 2003
por: Lo, Janice Y.C., et al.
Publicado: (2005)

Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong
por: Yin-Chun Yam, Loretta, et al.
Publicado: (2007)

Cost of Cerebellar Ataxia in Hong Kong: A Retrospective Cost-of-Illness Analysis
por: Stanley, Winser John, et al.
Publicado: (2020)

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa
por: Koltai, Mihaly, et al.
Publicado: (2023)

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong
por: Cheung, Tak Hong, et al.
Publicado: (2021)

A FREEZE IN TIME: PERCEPTION AND EXPERIENCE OF AMERICAN AND HONG KONG CHINESE OLDER ADULTS
por: Ho, Tinky Oi Ting, et al.
Publicado: (2019)

Grandparenting and Well-Being of Hong Kong Older Adults: The Mediating Role of Intergenerational Relationships
por: Lai, Daniel W L, et al.
Publicado: (2020)

Roles of Knowledge and Attitude in the Willingness of Nursing Students to Care for Older Adults in Hong Kong
por: Cheng, Winnie Lai-Sheung
Publicado: (2021)

Advancement in the medicolegal requirement for testamentary capacity assessment in older adults: the dilemmas in Hong Kong
por: Lam, Chi-Leung, et al.
Publicado: (2021)

Hospital Readmission among Older Medical Patients in Hong Kong
por: Kwok, T, et al.
Publicado: (1999)

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong
por: Cheung, Tak Hong, et al.
Publicado: (2023)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

The road to approved vaccines for respiratory syncytial virus
por: Ruckwardt, Tracy J.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7nli63hvq7c3n9tqca84injts5